title: Role of surgery, radiotherapy and chemotherapy in papillary tumors of the pineal region: a multicenter study.
abstract: Papillary tumor of the pineal region (PTPR), recently described as a distinct clinicopathological entity, can show aggressive biological behavior. The optimal therapeutic approach of PTPR has not been well defined. The role of surgery, radiotherapy, and chemotherapy in the treatment of PTPR was analyzed in a large multicenter series. In order to determine factors that influence prognosis, outcome data of a series of 44 patients with histopathologically proven PTPR were retrospectively analyzed. Of the 44 patients, 32 were still alive after a median follow-up of 63.1 months. Twelve patients experienced progressive disease, with seven undergoing two relapses and five more than two. Median overall survival (OS) was not achieved. Median progression-free survival (PFS) was 58.1 months. Only gross total resection and younger age were associated with a longer OS, radiotherapy and chemotherapy having no significant impact. PFS was not influenced by gross total resection. Radiotherapy and chemotherapy had no significant effect. This retrospective series confirms the high risk of recurrence in PTPR and emphasizes the importance of gross total resection. However, our data provide no evidence for a role of adjuvant radiotherapy or chemotherapy in the treatment of PTPR.
authors: Centre de Haute Energie, Centre de Radiothérapie Privé and ADeRTU, Nice, France.
authors: F
authors: F
authors: Fauchon
authors: M
authors: M
authors: Hasselblatt
authors: A
authors: A
authors: Jouvet
authors: J
authors: J
authors: Champier
authors: M
authors: M
authors: Popovic
authors: R
authors: R
authors: Kirollos
authors: T
authors: T
authors: Santarius
authors: S
authors: S
authors: Amemiya
authors: T
authors: T
authors: Kumabe
authors: D
authors: D
authors: Frappaz
authors: M
authors: M
authors: Lonjon
authors: M
authors: M
authors: Fèvre Montange
authors: A
authors: A
authors: Vasiljevic
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols; D002291:Carcinoma, Papillary / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D009367:Neoplasm Staging; D010870:Pineal Gland / Q000473:pathology*; D010871:Pinealoma / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D011379:Prognosis; D016634:Radiosurgery; D018714:Radiotherapy, Adjuvant; D015996:Survival Rate; D055815:Young Adult